These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18063832)

  • 1. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
    Kelly PJ; Morrow JD; Ning M; Koroshetz W; Lo EH; Terry E; Milne GL; Hubbard J; Lee H; Stevenson E; Lederer M; Furie KL
    Stroke; 2008 Jan; 39(1):100-4. PubMed ID: 18063832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death.
    Inzitari D; Giusti B; Nencini P; Gori AM; Nesi M; Palumbo V; Piccardi B; Armillis A; Pracucci G; Bono G; Bovi P; Consoli D; Guidotti M; Nucera A; Massaro F; Micieli G; Orlandi G; Perini F; Tassi R; Tola MR; Sessa M; Toni D; Abbate R;
    Stroke; 2013 Oct; 44(10):2901-3. PubMed ID: 23908067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke.
    Demir R; Ulvi H; Özel L; Özdemir G; Güzelcik M; Aygül R
    Acta Neurol Belg; 2012 Dec; 112(4):351-6. PubMed ID: 22581515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative Stress Biomarkers of Brain Damage: Hyperacute Plasma F2-Isoprostane Predicts Infarct Growth in Stroke.
    Lorenzano S; Rost NS; Khan M; Li H; Lima FO; Maas MB; Green RE; Thankachan TK; Dipietro AJ; Arai K; Som AT; Pham LD; Wu O; Harris GJ; Lo EH; Blumberg JB; Milbury PE; Feske SK; Furie KL
    Stroke; 2018 Mar; 49(3):630-637. PubMed ID: 29371434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA--Does One Size Fit All?
    Faigle R; Marsh EB; Llinas RH; Urrutia VC
    PLoS One; 2015; 10(10):e0141204. PubMed ID: 26517543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis.
    Loh PS; Butcher KS; Parsons MW; MacGregor L; Desmond PM; Tress BM; Davis SM
    Stroke; 2005 Dec; 36(12):2626-31. PubMed ID: 16269645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.
    Horstmann S; Kalb P; Koziol J; Gardner H; Wagner S
    Stroke; 2003 Sep; 34(9):2165-70. PubMed ID: 12907822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress after thrombolysis-induced reperfusion in human stroke.
    Domínguez C; Delgado P; Vilches A; Martín-Gallán P; Ribó M; Santamarina E; Molina C; Corbeto N; Rodríguez-Sureda V; Rosell A; Alvarez-Sabín J; Montaner J
    Stroke; 2010 Apr; 41(4):653-60. PubMed ID: 20185784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of the thrombolytic time window with minocycline in experimental stroke.
    Murata Y; Rosell A; Scannevin RH; Rhodes KJ; Wang X; Lo EH
    Stroke; 2008 Dec; 39(12):3372-7. PubMed ID: 18927459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
    Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
    Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke.
    Rodríguez-Yáñez M; Sobrino T; Arias S; Vázquez-Herrero F; Brea D; Blanco M; Leira R; Castellanos M; Serena J; Vivancos J; Dávalos A; Castillo J
    Stroke; 2011 Oct; 42(10):2813-8. PubMed ID: 21836082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
    Castellanos M; Leira R; Serena J; Blanco M; Pedraza S; Castillo J; Dávalos A
    Stroke; 2004 Jul; 35(7):1671-6. PubMed ID: 15166391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
    Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
    Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch.
    Chemmanam T; Campbell BC; Christensen S; Nagakane Y; Desmond PM; Bladin CF; Parsons MW; Levi CR; Barber PA; Donnan GA; Davis SM;
    Neurology; 2010 Sep; 75(12):1040-7. PubMed ID: 20720188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.